$Phenotyping of outpatients with heart failure with preserved ejection fraction and poor prognosis$

Phenotyping of outpatients with heart failure with preserved ejection fraction and poor prognosis

The applicability of the left ventricular global function index (LVGFI) and its derivative, determined by echocardiography, to distinguish clinical phenotypes in a cohort of patients with heart failure with preserved ejection fraction (HFpEF) is unknown.Aim. To evaluate the differential diagnostic...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. N. Larina, V. I. Lunev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-04-01
Series:	Российский кардиологический журнал
Subjects:	heart failure preserved ejection fraction global function index phenotype mortality derived index
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5759
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Novel Adiposity Indices Are Associated With Poor Prognosis in Heart Failure With Preserved Ejection Fraction Without the Obesity Paradox
by: Shuai Zhang, et al.
Published: (2024-11-01)

Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
by: Ruting Wang, et al.
Published: (2024-12-01)

Left atrioventricular coupling index measured by echocardiography in heart failure with preserved ejection fraction
by: Hai Nguyen Ngoc Dang, et al.
Published: (2025-07-01)

Phenotypic clusters and biomarkers profile in patients with chronic heart failure with preserved and mildly reduced left ventricular ejection fraction
by: Natalia A. Dragomiretskaya, et al.
Published: (2024-12-01)

The level of human epididymis protein 4 is associated with poor prognosis in patients with ejection fraction preserved heart failure
by: Yi Tang, et al.
Published: (2025-08-01)

State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age
by: Roy Rasalam, et al.
Published: (2025-06-01)

Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024-02-01)

Invasive haemodynamic assessment in heart failure with preserved ejection fraction
by: Phuuwadith Wattanachayakul, et al.
Published: (2025-06-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

Left atrial stiffness index in the identification of heart failure with preserved ejection fraction
by: N. E. Shirokov, et al.
Published: (2024-05-01)

Obesity paradox in chronic heart failure with moderately reduced or preserved left ventricular ejection fraction: impact on a prognosis for patients according to a five-year follow-up
by: P. P. Bidzilya, et al.
Published: (2023-07-01)

Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction
by: Song‐Yun Chu, et al.
Published: (2025-02-01)

Heart Failure with Preserved Ejection Fraction in Egypt: An Expert Opinion
by: Magdy Abdelhamid, et al.
Published: (2025-03-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry
by: Laura Landucci, et al.
Published: (2025-03-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

Diagnosis and treatment of heart failure with preserved ejection fraction in patients on hemodialysis
by: Kosaku Nitta, et al.
Published: (2024-10-01)

Importance of non‐cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction
by: Yasuhiro Hamatani, et al.
Published: (2025-02-01)

Prognostic Value of Resting Left Ventricular Sphericity Indexes in Coronary Artery Disease With Preserved Ejection Fraction
by: Ping Wu, et al.
Published: (2024-09-01)

Prognostic Value of the Global Left Ventricular Contractility Index in Patients with Severe Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction
by: Tony Li, et al.
Published: (2025-06-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Current diagnostic algorithms for chronic heart failure with preserved left ventricular ejection fraction
by: Ya. Yu. Maistrovych, et al.
Published: (2023-03-01)

Insulin resistance and heart failure with preserved ejection fraction. Pathogenetic and therapeutic crossroads
by: O. V. Tsygankova, et al.
Published: (2023-01-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01)

Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis
by: Parham Dastjerdi, et al.
Published: (2025-04-01)

Chronic Heart Failure with Preserved Ejection Fraction in A Comorbid Patient: Issues in Verification of A «Difficult» Diagnosis
by: O. V. Ponomareva, et al.
Published: (2025-05-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Heat shock proteins in the assessment of the course and prognosis of heart failure with preserved ejection fraction
by: Yu. S. Timofeev, et al.
Published: (2025-05-01)

Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2023-11-01)

Left atrial strain in assessing heart failure with preserved ejection fraction in hypertensive patients
by: E. S. Mazur, et al.
Published: (2022-09-01)

Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01)

Dietary Interventions in Heart Failure With Preserved Ejection Fraction
by: Hayley E. Billingsley, PhD, RDN, et al.
Published: (2025-01-01)

Association of visceral adiposity index (VAI) with prognosis in patients with metabolic syndrome and heart failure with reduced ejection fraction
by: Meiyin Wu, et al.
Published: (2025-03-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome.
by: V. A. Vasylenko
Published: (2015-09-01)